Tectonic Therapeutic | AVRO - Beneficio Bruto En Ventas





Beneficio Bruto En Ventas Cambio Fecha
Akebia Therapeutics USD 47.28M 1.7M 2025-12
Alnylam Pharmaceuticals USD 992.69M 167.68M 2026-06
Celltrion KRW 39.29B 7.7B 2026-03
Cspc Pharmaceutical CNY 4.01B 329.18M 2025-12
Deva Holding AS TRY 1.32B 235.77M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 19.61B 2.49B 2026-06
Gilead Sciences USD 6.8B 1.29B 2026-06
Ionis Pharmaceuticals USD 265M 22M 2026-06
Kangmei Pharma CNY 238.34M 31.95M 2026-03
Karyopharm Therapeutics USD 33.72M 1.13M 2026-03
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Laboratorios Farma EUR 105.28M 177.08M 2025-06
MacroGenics USD 11.24M 19.87M 2026-03
Medical Developments International AUD 7.35M 7.37M 2025-06
Neuren Pharmaceuticals AUD 6.69M 6.37M 2025-06
Organigram Holdings CAD 16.41M 6.91M 2026-03
Pfizer USD -248M 11.29B 2026-06
Pharma Mar EUR 44.87M 5.63M 2026-06
Qiagen NV USD 340.39M 30.78M 2026-06
Roche Holding CHF 22.69B 600M 2026-06
Sangamo BioSciences -2.39M 1.09M 2024-06
Sanofi EUR 8.71B 602M 2026-06
Sarepta Therapeutics USD 251.15M 370.2M 2026-06
Sartorius EUR 433.1M 18.6M 2026-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Takeda JPY 813.22B 124.39B 2026-06
Tilray USD 57.47M 10.16M 2025-06
Zealand Pharma A/S 34M 34.92M 2026-03
Zz Pientze Pharmaceu CNY 1.16B 860.2M 2026-03